Lupin acquires Huminsulin in India to strengthen diabetes care portfolio

Global pharma company Lupin announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly), aiming to expand its diabetes …

Share on Facebook

Tweet

Follow us

Save